To explore effective strategies for EDEM3 overexpression in CRC therapy that can reverse resistance and lower toxicity, we used CT26 cells to express empty vector (EDEMEV) or harbour EDEM3 overexpression (EDEM3OE) in the BALB/c mice. Here, EDEM3 is linked to colorectal carcinoma.